Expressional alterations and transcript isoforms of metastasis suppressor genes (KAI1 & kiss1) in breast cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2785-2791

  Mooez, M ^a   Malik, F A ^a   Kayani, M A ^a   Ashid, A ^b   Zahid, Z ^c   Khan, K ^c  

^a COMSATS Institute of Information and Technology ^*  (Pakistan)

^b PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

^c ARMY MEDICAL COLLEGE   (Pakistan)

Author keywords

Breast cancer; KAI1; KISS1; Metastasis suppressor genes; Mrna expression

Indexed keywords

EID: 84858258014     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Adachi M, Taki T, Ieki Y, et al (1996). Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res, 56, 1751-5.
2. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA (1993). Molecular aspects of tumor cell invasion and metastasis. Cancer, 71, 1368-83.
3. Baloch TA, Iqbal P (2006). Breast carcinoma in Karachi clinical & pathological features. Med Channel, 12, 47-8.
4. Bhurgri Y (2004). Karachi Cancer Registry data-implications for the national cancer control program of Pakistan. Asian Pac J Cancer Prev, 5, 77-82.
5. Chomczynski P, Sacchi N (2006). The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nature, 1, 581-5.
6. Davies G, Jiang W.G., and Mason M.D. (2000) Cell-cell adhesion and signaling intermediates in human prostate cancer. J Urol, 163, 985-92.
7. Debies MT, Welch DR (2002). Genetic basis of human breast cancer metastasis. J Mamm Gliand Biol Neopl, 6, 441-51
8. Dhar DK, Naora H, Kubota H, et al (2004). Downregulation of KiSS-1 expression is responsible for tumour invasion and worse prognosis in gastric carcinoma. Int J Cancer, 111, 868-72.
9. Dong JT, Isaacs WB, Barrett JC, Isaacs JT (1997). Genomic organization of the human KAI1 metastasis-suppressor gene. Genomics, 41, 25-32.
10. Dong JT, Lamb PW, Rinker-Schaeffer CW, et al (1995). KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science, 268, 884-6.
11. Dong JT, Suzuki H, Pin SS, et al (1996). Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res, 56, 4387-90.
12. Farhadieh RD, Smee R, Ow K, et al (2004). Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival. Cancer Lett, 213, 91-8.
13. Guan-Zhen Y, Ying C, Can-Rong N, et al (2007). Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer. Int J Exp Pathol, 88, 175-83.
14. Harms JF, Welch DR, Miele ME (2003). KISS1 metastasis suppression and emergent pathways. Clin Exp Metastasis, 20, 11-8.
15. Harris L, Fritsche H, Mennel R, et al (2007). Update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol, 25, 5287-12.
16. Horak CE, Lee JH, Marshall JC, Shreeve SM, Steeg PS (2008). The role of metastasis suppressor genes in metastatic dormancy. APMIS, 116, 586-601.
17. Houle CD, Ding XY, Foley JF, et al (2002). Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol, 86, 69-78.
18. Huang H, Groth J, Sossey-Alaoui K, et al (2005). Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Clin Cancer Res, 11, 4357-64
19. Ichikawa T, Ichikawa Y, Isaacs JT (1991). Genetic factors and metastatic potential of prostatic cancer. Cancer Surv, 11, 35-42.
20. Ikeguchi M, Hirooka Y, Kaibara N (2003). Quantitative reverse transcriptase polymerase chain reaction analysis for KISS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. J Cancer Res Clin Oncol, 129, 531-5.
21. Jackson P, Millar D, Kingsley E, et al (2000). Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines. Cancer Lett, 157, 169-76.
22. Jackson P, Ow K, Yardley G, et al (2003). Downregulation of KAI1 mRNA in localized prostate cancer and its bony metastases does not correlate with p53 overexpression. Prostate Cancer Prostatic Dis, 6, 174-81.
23. Jackson P, Rowe A, Grimm MO (2007). An alternatively spliced KAI1 mRNA is expressed at low levels in human bladder cancers and bladder cancer cell lines and is not associated with invasive behaviour. Oncol Rep, 18, 1357-1363.
24. Kawana Y, Komiya A, Ueda T, et al (1997). Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer. Prostate, 32, 205-13.
25. Kotani M, Detheux M, Vandenbogaerde A, et al (2001). The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G proteincoupled receptor GPR54. J Biol Chem, 276, 34631-6.
26. Lee JH, Welch DR (1997). Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res, 57, 2384-7.
27. Lee JH, Seo YW, Park SR, Kim YJ, Kim KK (2003). Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res, 63, 7247-55.
28. Liu WM, Zhang XA (2006). KAI1/CD82, a tumor metastasis suppressor. Cancer Lett, 240, 183-94.
29. Lombardi DP, Geradts J, Foley JF, et al (1999). Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res, 59, 5724-31.
30. Malik FA, Kayani MA, Iqbal H, et al (2008). Screening of coding region of metastasis suppressor genes KISS1 and KAI-1 for germ line mutations in breast cancer patients. Gene Therapy Molec Biol, 12, 239-46.
31. Marreiros A, Dudgeon K, Dao V, et al (2005). KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells. Oncogene, 24, 637-49.
32. Martin T.A., Watkins G, Jiang W.G. (2005). KISS-1 expression in human breast cancer. Clin Exp Metastasis, 22, 503-11.
33. Mashimo T, Watabe M, Hirota S, et al (1998) The expression of the KAI gene, is directly activated by p53. Proc Natl Acad Sci USA, 95, 11307-11.
34. Maurer CA, Graber HU, Friess H, et al (1999). Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases. Surgery, 126, 869-80.
35. Mitchell DC, Abdelrahim M, Weng J, et al (2006). Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1. J Biol Chem, 281, 51-8.
36. Miyazaki T, Kato H, Shitara Y, et al (2000). Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer, 89, 955-62.
37. Motozawa Y, Uzawa K, Ono K, et al (2008). Decreased expression of the KAI1 gene involved in progression and metastasis of tongue squamous cell carcinoma. .,84, 261 261-8.
38. Ohtaki T, Shintani Y, Honda S, et al (2001). Metastasis suppressor Kiss-1 encodes a peptide ligand of a G-protein-coupled receptor. Nature, 411, 613-7.
39. Rezaianzadeh A, Peacock J, Reidpath D, et al (2009). Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran. BMC Cancer, 9, 1-11
40. Ringel MD, Hardy E, Bernet VJ, et al (2002) Metastin receptor is overexpressed in papillary fthyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab, 87, 2399.
41. Sanchez-Carbayo M., Capodieci P, Cordon-Cardo C (2003) Tumor suppressor role of KiSS-1 in bladder cancer. Loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol, 162, 609-617
42. Sato T, Tanigami A, Yamakawa K, et al (1990). Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res, 50, 7814-7819.
43. Schindi M, Birner P, Bachtiary B, et al (2000). The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer. Anticancer Res, 20, 4551-5.
44. Shirasaki F, Takata M, Hatta N, Takehara K (2001). Loss of expression of the metastasis suppressor gene KiSS-1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res, 61, 7422-5.
45. Shoji S, Tang XY, Umemura S, et al (2010). Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Eur Urol, 55, 441-9.
46. Siddiqui M, Kayani N, Sulaiman S, et al (2000). Breast carcinoma in Pakistani females: a morphological study of 572 breast specimens. J Pak Med Assoc, 50, 174-7
47. Stafford LJ, Xia C, Ma W, Cai Y, Liu M (2002). Identification and characterization of mouse metastasis-suppressor KiSS1 and its Gprotein-coupled receptor. Cancer Res, 62, 5399-04.
48. Stark AM, Tongers K, Maass N, Mehdorn HM, Held-Feindt J (2005). Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol, 131, 191-8.
49. Tagawa K, Arihiro K, Takeshima Y, et al (1999). Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma. Jpn J Cancer Res, 90, 970-6.
50. Tsutsumi S, Shimura T, Morinaga N, et al (2005). Loss of KAI1 expression in gastric cancer. Hepatogastroenterology, 52, 281-4.
51. Uchida S, Shimada Y, Watanabe G, et al (1999). Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer, 79, 1168-73.
52. Wang XY, Liu T, Zhu CZ, et al (2005). Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray. Chin J Cancer, 24, 1091-5.
53. Welch DR, Steeg PS, Rinker-Schaeffer CW (2000). Molecular biology of breast cancer metastasis - Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res, 2, 408-16.
54. Wright MD, Tomlinson MG (1994). The ins and outs of transmembrane 4 superfamily. Immunol Today, 15, 588-94.
55. Yamada SD, Hickson JA, Hrobowski Y, et al (2002). Mitigen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res, 62, 6717-23.
56. Yang X, Wei L, Tang C, et al (2000). Kai1 protein is down-regulated during the progression of human breast cancer. Clin Cancer Res, 6, 3424-9.
57. Yang X, Welch RD, Phillips KK, et al (1997). KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett, 119, 149-55.
58. Yoshida BA, Dubauskas Z, Chekmareva MA, et al (1999). Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res, 59, 5483-7.
59. Yoshida BA, Sokoloff MM, Danny RW, Carrie WR (2000). Metastasis-suppressor genes. J Natl Cancer Inst, 92, 1717-30.
60. Yu Y, Yang JL, Markovic B, et al (1997). Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancer. J Clin Cancer Res, 3, 1045-9.